Defendant Name:
Opko Health Inc.
Defendant Type:
Public Company
SIC Code:
2834
CUSIP:
68375N10
Initial Case Details
Legal Case Name
SEC v. Barry C. Honig, John Stetson, Michael Brauser, John R. O'Rourke III, Mark Groussman, Phillip Frost, Robert Ladd, Elliot Maza, Brian Keller, John H. Ford, Fil Alpha Capital Anstalt, ATG Capital LLC, Frost Gamma Investments Trust, GRQ Consultants, Inc., HS Contrarian Investments, LLC, Grander Holdings, Inc., Melechdavid, Inc., OPKO Health, Inc., Southern Biotech, Inc., and Stetson Capital Investments Inc.
First Document Date
07-Sep-2018
Initial Filing Format
Civil Proceeding
Case Number
18-cv-08175
Allegation Type
Market Manipulation
Federal District Court
New York, Southern District of New York
Violations Alleged
•
Section 13(d) Exchange Act; Rule 13d-1(a) Exchange Act
Related Violations Alleged
Opko Health Inc. is alleged to have aided and abetted
Barry C. Honig's violation of Sec 10(b) + Rule 10b-5 of the Exchange Act.
Opko Health Inc. is alleged to have aided and abetted
John Stetson's violation of Sec 10(b) + Rule 10b-5 of the Exchange Act.
Opko Health Inc. is alleged to have aided and abetted
Michael Brauser's violation of Sec 10(b) + Rule 10b-5 of the Exchange Act.
Opko Health Inc. is alleged to have aided and abetted
John R. O'Rourke III's violation of Sec 10(b) + Rule 10b-5 of the Exchange Act.
Opko Health Inc. is alleged to have aided and abetted
Barry C. Honig's violation of Sec 17(a)(1) of the Securities Act.
Opko Health Inc. is alleged to have aided and abetted
John Stetson's violation of Sec 17(a)(1) of the Securities Act.
Opko Health Inc. is alleged to have aided and abetted
Michael Brauser's violation of Sec 17(a)(1) of the Securities Act.
Opko Health Inc. is alleged to have aided and abetted
John R. O'Rourke III's violation of Sec 17(a)(1) of the Securities Act.
Opko Health Inc. is alleged to have aided and abetted
Barry C. Honig's violation of Sec 17(a)(3) of the Securities Act.
Opko Health Inc. is alleged to have aided and abetted
John Stetson's violation of Sec 17(a)(3) of the Securities Act.
Opko Health Inc. is alleged to have aided and abetted
Michael Brauser's violation of Sec 17(a)(3) of the Securities Act.
Opko Health Inc. is alleged to have aided and abetted
John R. O'Rourke III's violation of Sec 17(a)(3) of the Securities Act.
Resolutions
First Resolution Date
10-Jan-2019
Headline Total Penalty and Disgorgement
$100,000
Related Documents:
SEC Charges Microcap Fraudsters for Roles in Lucrative Market Manipulation Schemes
On September 7, 2018, the SEC issued a litigation release regarding charges against Opko Health Inc., stating: "The Securities and Exchange Commission today charged a group of ten individuals and ten associated entities for their participation in long-running fraudulent schemes that generated over $27 million from unlawful stock sales and caused significant harm to retail investors who were left holding virtually worthless stock."
2018-182
07-Sep-2018
Press Release--Civil Action
SEC Charges Microcap Fraudsters for Roles in Lucrative Market Manipulation Schemes
On September 7, 2018, the SEC issued a press release regarding charges against Opko Health Inc., stating: "The Securities and Exchange Commission today charged a group of ten individuals and ten associated entities for their participation in long-running fraudulent schemes that generated over $27 million from unlawful stock sales and caused significant harm to retail investors who were left holding virtually worthless stock."
Complaint and Jury Demand
The Court stated: "This case involves three highly profitable "pump-and-dump" schemes perpetrated by Honig, Stetson, Brauser, O'Rourke, Groussman, and Frost, and their entities GRQ, SCI, Grander, HSCI, Melechdavid, ATG, Opko, FGIT, and Southern Biotech from 2013 through 2018 in the stock of three public companies (Company A, Company B, and Company C) that, while enriching Defendants by millions of dollars, left retail investors holding virtually worthless shares."
Final Judgment as to Opko Health, Inc.
The Court stated: "The Securities and Exchange Commission having filed a Complaint and Defendant OPKO Health, Inc. having entered a general appearance; consented to the Court's jurisdiction over Defendant and the subject matter of this action; consented to entry of this Final Judgment without admitting or denying the allegations of the Complaint (except as to jurisdiction); waived findings of fact and conclusions of law; and waived any right to appeal from this Final Judgment."
Other Defendants in Action:
